RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bionovate Technologies Stock

Bionovate Technologies Equity 2024

Bionovate Technologies Equity

-503,210.01 USD

Ticker

BIIO

ISIN

US09074V2025

In 2024, Bionovate Technologies's equity was -503,210.01 USD, a 0% increase from the 0 USD equity in the previous year.

Bionovate Technologies Aktienanalyse

What does Bionovate Technologies do?

Bionovate Technologies Corp is a biotechnology company specializing in the research, development, and marketing of innovative medical devices for the diagnosis and treatment of skin diseases. It was founded in 2017 and is headquartered in Vancouver, Canada. Bionovate Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Bionovate Technologies's Equity

Bionovate Technologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bionovate Technologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bionovate Technologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bionovate Technologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bionovate Technologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bionovate Technologies stock

What is the equity of Bionovate Technologies this year?

Bionovate Technologies has equity of -503,210.01 USD this year.

What was the equity of Bionovate Technologies compared to the previous year?

The equity of Bionovate Technologies has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Bionovate Technologies?

A high equity is advantageous for investors of Bionovate Technologies as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Bionovate Technologies?

A low equity can be a risk for investors of Bionovate Technologies, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Bionovate Technologies affect the company?

An increase in equity of Bionovate Technologies can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Bionovate Technologies affect the company?

A reduction in equity of Bionovate Technologies can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Bionovate Technologies?

Some factors that can affect the equity of Bionovate Technologies include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Bionovate Technologies so important for investors?

The equity of Bionovate Technologies is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Bionovate Technologies take to change the equity?

To change equity, Bionovate Technologies can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Bionovate Technologies pay?

Over the past 12 months, Bionovate Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bionovate Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Bionovate Technologies?

The current dividend yield of Bionovate Technologies is .

When does Bionovate Technologies pay dividends?

Bionovate Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bionovate Technologies?

Bionovate Technologies paid dividends every year for the past 0 years.

What is the dividend of Bionovate Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bionovate Technologies located?

Bionovate Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bionovate Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bionovate Technologies from 12/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/2/2024.

When did Bionovate Technologies pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Bionovate Technologies in the year 2023?

In the year 2023, Bionovate Technologies distributed 0 USD as dividends.

In which currency does Bionovate Technologies pay out the dividend?

The dividends of Bionovate Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bionovate Technologies

Our stock analysis for Bionovate Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionovate Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.